Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival

Reactivation of tumor infiltrating T lymphocytes (TILs) with immune checkpoint inhibitors or co-stimulators has proven to be an effective anti-cancer strategy for a broad range of malignancies. However, epithelial ovarian cancer (EOC) remains largely refractory to current T cell-targeting immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlaming, Martijn, Bilemjian, Vrouyr, Freile, Jimena Álvarez, Melo, Vinicio, Plat, Annechien, Huls, Gerwin, Nijman, Hans W., de Bruyn, Marco, Bremer, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633842/
https://www.ncbi.nlm.nih.gov/pubmed/36341460
http://dx.doi.org/10.3389/fimmu.2022.1031746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633842/
https://www.ncbi.nlm.nih.gov/pubmed/36341460
http://dx.doi.org/10.3389/fimmu.2022.1031746

Ejemplares similares